Cooper Financial Group Horizon Therapeutics Public LTD CO Transaction History

Cooper Financial Group

  • $670 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
BUY
$107.32 - $113.5 $76,089 - $80,471
709 Added 18.81%
4,478 $488,000
Q4 2022

Jan 13, 2023
BUY
$62.39 - $113.8 $27,451 - $50,072
440 Added 13.22%
3,769 $0
Q3 2022

Oct 13, 2022
BUY
$58.92 - $84.67 $196,144 - $281,866
3,329 New
3,329 $206,000

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email